Myriam Chalabi, MD

Trials

Studies that name Myriam Chalabi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:33 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT06279130 · Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations

  The Netherlands Cancer Institute · recruiting · Resectable MMR-deficient Solid Tumors, Resectable MMR-proficient Solid Tumors · principal investigator
• Ph2
  NCT05131919 · Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers

  The Netherlands Cancer Institute · active not recruiting · Colorectal Cancer · principal investigator
• Ph2
  NCT04017455 · Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)

  The Netherlands Cancer Institute · active not recruiting · Rectal Cancer · principal investigator
• Ph2
  NCT03448835 · Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

  The Netherlands Cancer Institute · active not recruiting · Stomach Cancer, Gastro Esophageal Junction Cancer · principal investigator
• Ph2
  NCT03026140 · Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

  The Netherlands Cancer Institute · recruiting · Colon Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.